Pancreatic Cancer News

Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.

Jun

24

Researchers From University Of Pittsburgh, Hillman Cancer Center Report Recent Findings In Pancreatic Cancer

Researchers detail in 'Chemoprevention strategies for pancreatic cancer,' new data in pancreatic cancer. According to recent research from the United States, Pancreatic cancer has a poor prognosis and is often diagnosed at an advanced stage, which makes it difficult to treat. The low survival rate of patients with pancreatic cancer points towards an increased need for novel therapeutic and chemopreventive strategies and also early detection of this disease.

Jun

17

Cysts Hold Clues To Pancreatic Cancer

Working with researchers from the University of Michigan and Indiana University, Van Andel Research Institute (VARI) investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancer.

Jun

17

Government Moves To Oversee Genetic Tests Aimed At Consumers

During a stay at a resort two years ago, Carol Arand purchased $4,000 in genetic tests after a spa physician praised their potential to improve her health. If ever she got sick, Arand reasoned, she could take the results to her doctor. I hoped that this genetic fingerprint could be useful, she said.

Jun

17

New Genomic Cancer Care Alliance Formed To Study Whole-Genome Sequencing In Cancer Treatment

Life Technologies Corporation (NASDAQ: LIFE) announced the creation of the Genomic Cancer Care Alliance to help people battling cancer gain access to treatment options found through analysis of their genomic information. Founding partners include Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute (TGen).The announcement came during the Consumer Genetics Conference being held June 2-4 in Boston.

Jun

17

Blood-Sugar Lowering Medications May Increase Risk For False Positive Results In Cancer Screenings

A study presented at SNM's 57th Annual Meeting suggests that medication ingested to control blood-sugar levels can skew the results of cancer screenings using positron emission tomography (PET), a molecular imaging technique, by increasing absorption in the gut of the PET imaging agent called fluorodeoxyglucose (18F- FDG), which mimics sugar inside the body.

Jun

10

Results From A Study Testing Methylphenidate For Cancer-Related Fatigue Indicate That It Is Certainly Not A Panacea But May Be Effective For Some Groups Of Patients

Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently completed a study testing methylphenidate in the treatment of cancer-related fatigue and found that, while it did not improve fatigue for a broad group of patients, the data did not rule out a benefit for those with stage III/IV cancer.

Jun

10

Research Conducted At University Of Arkansas For Medical Sciences, Medical Has Provided New Information About Obesity

Researchers detail in 'Consideration of the food environment in cancer risk reduction,' new data in obesity. According to a study from the United States, Recently, there has been increased attention to the food environment's impact on chronic disease, specifically obesity and cardiovascular disease.

Jun

03

Tiny Chemotherapy Bubbles Deliver A One-Two Punch To Knock Out Cancer

A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with many different kinds of cancers.

Jun

03

Tumor-Targeted Rexin-G Prolongs Survival In Gemcitabine-Resistant Metastatic Pancreas Cancer In Advanced Phase I And II Studies ASCO 2010

Epeius Biotechnologies Corporation (www.epeiusbiotech.com) announces the results of the clinical study entitled Phase I and II Studies of Intravenous Rexin-G as Monotherapy for Gemcitabine-resistant Metastatic Pancreas Cancer at the ASCO Annual Meeting on June 6, 2010. The presentation will be discussed by Dr. Howard W. Bruckner, Bruckner Oncology, New York, NY.

May

25

Is Tea As Healthy As Claimed?

A few years ago a thirsty Angela Cunningham walked into a convenience store and was disappointed in her choices for a drink. She saw the row of fountain drinks and coolers of other bottled options and wondered about health aspects of them all. She would look at the ingredient list on the labels and found sugars, artificial sweeteners or preservatives and additives she didn't want.

Page(s): Prev 12...8 9 10 11 12 13 14 ...6667 Next 

We care about your feedback. Let us know how we can improve your CancerCompass experience.